Euroapi (EAPIF) Stock Price, News & Analysis

Company Overview

Euroapi S.A. develops, manufactures, markets, and distributes active pharmaceutical ingredients and intermediates used in the formulation of medicines for human and veterinary use. It provides contract development manufacturing organization for different classes of tides that uses solid phase chemistry; particle engineering; microbial fermentation; small molecules synthesis; prostaglandins; steroids and hormones; and opiates and controlled substances, as well as lipids. The company was incorporated in 2020 and is based in Paris, France.

Key Stats

• Today's Range: C$3.95 to C$3.95
• 50-Day Range: C$3.95 to C$3.95
• 52-Week Range: C$2.75 to C$12.25
• Volume: N/A
• Average Volume: 1,138 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

EAPIF Stock Analysis - Frequently Asked Questions

How have EAPIF shares performed this year?

Euroapi's stock was trading at C$5.10 on January 1st, 2024. Since then, EAPIF stock has decreased by 22.5% and is now trading at C$3.95.
View the best growth stocks for 2024 here.

How do I buy shares of Euroapi?

Shares of EAPIF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Drug Manufacturers - Specialty & Generic
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:EAPIF
• CUSIP: N/A
• CIK: N/A
• Web: www.euroapi.com
• Phone: 33 1 89 20 62 00
• Fax: N/A
• Employees: 3,329
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A